Deutsch English Français

Contact

EP3172197

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3172197

EP3172197 - BENZIMIDAZOLE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR MODULATORS AND USES THEREOF [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 01.02.2019 Database last updated on 01.10.2024
Former	Request for examination was made Status updated on 28.04.2017
Former	The international publication has been made Status updated on 21.12.2016
Most recent event Tooltip	01.02.2019	Application deemed to be withdrawn	published on 06.03.2019 [2019/10]
Applicant(s)	For all designated states Innov17 LLC 760 Parkside Avenue Suite 208 Brooklyn, NY 11226 / US
	[2017/22]
Inventor(s)	01 / TILLEY, Jefferson 2540 NW Brickyard Street Bend, OR 97701 / US
	02 / BLINN, James 693 Rolling Thunder Drive O'fallon, MO 63368 / US
	03 / GAWECO, Anderson 760 Parkside Avenue Suite 208 Brooklyn, NY 11226 / US
	[2017/22]
Representative(s)	Plasseraud IP 104 Rue de Richelieu CS92104 75080 Paris Cedex 02 / FR
	[N/P]
Former [2017/22]	Cabinet Plasseraud 66 rue de la Chaussée d'Antin 75440 Paris Cedex 09 / FR
Application number, filing date	15824803.9	24.07.2015
	[2017/22]
	WO2015US41939
Priority number, date	US201462029094P	25.07.2014 Original published format: US 201462029094 P
	[2017/22]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2016014918
	Date:	28.01.2016
	Language:	EN
	[2016/04]
	Type:	A1 Application with search report
	No.:	EP3172197
	Date:	31.05.2017
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 28.01.2016 takes the place of the publication of the European patent application.
	[2017/22]
Search report(s)	International search report - published on:	US	28.01.2016
	(Supplementary) European search report - dispatched on:	EP	14.02.2018
Classification	IPC:	C07D401/14, C07D405/14, C07D417/14, A61K31/445, A61K31/55, A61P1/00, A61P11/00, A61P17/06, A61P29/00	[2018/11]
	CPC:	C07D487/08 (EP,US); A61P1/00 (EP); A61P11/00 (EP); A61P17/06 (EP); A61P29/00 (EP); C07D401/14 (EP,US); (+) C07D403/14 (EP,US) (-)
	Former IPC [2017/22]	C07D401/14, C07D405/14, C07D417/14
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/22]
Title	German:	BENZIMIDAZOLRETINSÄUREREZEPTORVERWANDTE WAISENREZEPTORMODULATOREN UND VERWENDUNGEN DAVON	[2017/22]
	English:	BENZIMIDAZOLE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR MODULATORS AND USES THEREOF	[2017/22]
	French:	MODULATEURS À BASE DE BENZIMIDAZOLE DU RÉCEPTEUR ORPHELIN LIÉ AU RÉCEPTEUR DE L'ACIDE RÉTINOÏQUE ET LEURS UTILISATIONS	[2017/22]
Entry into regional phase	21.12.2016	National basic fee paid
	21.12.2016	Search fee paid
	21.12.2016	Designation fee(s) paid
	21.12.2016	Examination fee paid
Examination procedure	21.12.2016	Amendment by applicant (claims and/or description)
	21.12.2016	Examination requested [2017/22]
	21.12.2016	Date on which the examining division has become responsible
	13.09.2018	Application deemed to be withdrawn, date of legal effect [2019/10]
	19.10.2018	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2019/10]
Fees paid	Renewal fee
	26.05.2017	Renewal fee patent year 03
	11.07.2018	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]WO2014028597 (MERCK SHARP & DOHME [US]) [A] 1 * example -; claim - *;
		[A]WO2013159095 (GAWECO ANDERSON [US], et al) [A] 1 * claim - *
	International search	[Y]WO2014028597 (MERCK SHARP & DOHME [US]) [Y] 1-19, 20A, 20B, 21-23, 24/1, 24/21, 25/1, 25/21, 26/25/1, 26/25/21, 27/25/1, 27/25/21 * ; page 3, lines 22-26; page 4, lines 1-26; page 5, lines 1-4, 11; page 16, lines 20-26; page 17, lines 6-14; page 18, lines 13-22; page 19, lines 4-12; page 20, lines 8-23; page 24, lines 7-15; page 29, lines 28-31; page 30, lines 1-2; page 31, lines 11-14 *;
		[Y]WO2013037960 (ESTEVE LABOR DR [ES], et al) [Y] 1-19, 20A, 20B, 21-23, 24/1, 24/21, 25/1, 25/21, 26/25/1, 26/25/21, 27/25/1, 27/25/21 * ; page 4; lines 18-26 *;
		[Y]US2007054903 (KIM TAE-SEONG [US], et al) [Y] 1-19, 20A, 20B, 21-23, 24/1, 24/21, 25/1, 25/21, 26/25/1, 26/25/21, 27/25/1, 27/25/21 * ; paragraphs [0011], [0031], [0038], [0044], [0046], [0049]-[0054], [0111], [0114], [0118]-[0121], [0154] *;
		[A]WO2013159095 (GAWECO ANDERSON [US], et al) [A] 1-19, 20A, 20B, 21-23, 24/1, 24/21, 25/1, 25/21, 26/25/1, 26/25/21, 27/25/1, 27/25/21 * ; paragraphs [0010]-[0011], [0014], [0034], [0036], [0053] *;
		[A]US6300342 (HECKEL ARMIN [DE], et al) [A] 1-19, 20A, 20B, 21-23, 24/1, 24/21, 25/1, 25/21, 26/25/1, 26/25/21, 27/25/1, 27/25/21 * ; entire document *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p